Press ReleasesNew Medical Cannabis Clinic Opens In Guernsey To Support...

New Medical Cannabis Clinic Opens In Guernsey To Support Expanding Patient Community


A NEW clinic giving islanders the opportunity to be prescribed medical cannabis is opening its doors in St Martin this week. The Medical Cannabis Clinic is partnering with St Martin’s Grand Rue Pharmacy to offer face to face consultations with Dr Scott Mitchell. The Medical Cannabis Clinic had been previously providing islanders access to the medicine through their clinics in the UK, however, this will be the first time they have offered their services from a locally-based centre.

It also means patients will no longer have to pay the import fee for medicines to be shipped from mainland UK. Since earlier this year, patients had been paying £25 to import their prescriptions of medical cannabis from the UK. This new clinic means islanders will be able to access their prescriptions more easily and faster from an island-based pharmacy. It’s also hoped this new clinic will improve access for patients and help those who are currently without a prescription but would benefit from the medicine.

Medical cannabis was legalised in the UK in November 2018 and is used to treat a variety of chronic pain conditions such as MS, fibromyalgia and endometriosis. It can also be used for gastrointestinal disorders such as IBS, as well as epilepsy and mental health disorders such as anxiety and depression. The new St Martins Clinic is currently taking bookings online at and will begin face to face appointments on Tuesday 7th June.

Dr Scott Mitchell said: “Cannabis based medicines have a huge potential to help patients with a vast range of illnesses and symptoms. Although it remains unlicensed, it has a good safety profile and can be a useful alternative when conventional therapies have been ineffective. Having a clinic here on the island means that we can provide the best quality of care, seeing patients face to face for their consultations.”

Sophie Gamwell, Head of Operations at Lyphe Group said: “This is an important step in ensuring the expanding patient community in Guernsey receives the highest level of care and most cost effective appointments on the island. Crucially, this new partnership means patients are able to receive their medication quicker and have their medication dispensed directly from St Martin’s Rue Pharmacy.”

Latest news

Germany Seeing Sense, High Tide Strikes Deal With Major German Player, European Expansion For Bedrocan, Danish Buy-Out, Greek First, £2m UK Hemp Boost

THE German Government’s refreshingly honest approach to drugs and addiction is being demonstrated with a focus on the harms...

European Cannabis Stocks Review: Akanda Announces ‘First Significant Revenue Above Initial Projections’, Jazz Pharma Reimbursement Recommendation & Kanabo Climbs

Akanda  Akanda has enjoyed a sharp recovery in its share price this week, seeing its value return to levels not...

15% Of European Consumers Have Tried CBD, But Industry Held Back By ‘High Turnover Rate’ Of Users

THE European CBD market is set to see a ‘massive influx’ of previous and new consumers to the market...

Malta’s Pioneering Legal Cannabis Club Framework Announced, But Concerns Raised Licence Fees Could Push Many To Black Market

ON Friday (January 27) the Maltese Authority for the Responsible Use of Cannabis (ARUC) announced new guidelines set to...

Cannovum AG Establishes Cultivation Alliance For Germany

PRESS RELEASE CANNOVUM AG is currently founding the premier cultivation alliance for recreational cannabis in Germany. The aim of the...

Jazz Pharmaceuticals Receives NICE Recommendation For The Reimbursement Of Epidyolex (Cannabidiol) For The Treatment Of Seizures Associated With Tuberous Sclerosis Complex In England

PRESS RELEASE JAZZ Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Epidyolex® (cannabidiol,100 mg/mL oral solution), developed by GW Pharmaceuticals ("GW"; now...

Must read

You might also likeRELATED
Recommended to you